Identifying effective therapeutic treatment strategies is a major challenge to improving outcomes for patients with breast cancer. To gain a comprehensive understanding of how clinically relevant anti ...
Patients with newly diagnosed multiple myeloma (NDMM) typically receive induction therapy consisting of at least a proteasome inhibitor (PI), an immunomodulatory imide drug (IMiD), and a ...
HistoIndex, a leader in AI-powered digital pathology solutions for fibrosis assessment, and D&D Pharmatech, today announced positive results from HistoIndex's AI-based quantitative analysis of liver ...